Non-profit Drugs: a first in France!
Thanks to a new decree, “Drugs for innovative therapy”, Genethon, the AFM-Telethon laboratory, will be able to commercialize products from its research. A first in the non-profit arena.
Author(s) : Handicap.fr – E.Dal’Secco http://www.handicap.fr
Read the article [PDF – 18,7 ko]
“Drugs for innovative therapies”: a new step for AFM-Telethon and its Genethon laboratory.
Read the article [PDF – 21,4 ko]
A “Nobel Prize” for Genethon
(Reporter : Julien Heyligen)
Friday November 30th, 2012: « Developing antisense oligonucleotides as a genetic therapy for Duchenne Muscular Dystrophy » Pr Francesco Muntoni, Professor of Paediatric Neurology, UCL Institute of Child Health and Great Ormond Street Hospital for Children (GOSH), Dubowitz Neuromuscular Centre, London, UK.